Reuters
Pfizer. BioNTech seek to revoke CureVacs patent infringement claims – Pfizer and its German partner BioNTech have filed proceedings at the High Court of England Wales seeking judgment that their COVID-19 vaccine, based on mRNA technology, does not infringe on CureVacs European patents, according to a regulatory filing on Friday. …
